Figure 6.

Expression of the Novel Exon in LN-95 and 22Rv1 cells. (a) LN-95 cells were treated with control si or AR-V7-siRNA and cells were harvested at 72 h for western blotting and probed with AR 441 and tubulin antibodies. (b) LN-95 cells were treated with control si, si-V7, and control si + R1881, and cells were harvested at 72 h and subjected to qPCR with the primers comprising PGAP2 Novel Exon and Exon 4. (c) PGAP2 Novel Exon and Exon 4 qPCR expression in 22Rv1 vehicle and R1881 treated cells.